Terms: = Ovarian cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884 AND Treatment
58 results:
1. hsp90 is a potential risk factor for ovarian cancer prognosis: an evidence of a Chinese clinical center.
Duan C; Li K; Pan X; Wei Z; Xiao L
BMC Cancer; 2023 May; 23(1):489. PubMed ID: 37259027
[TBL] [Abstract] [Full Text] [Related]
2. Mass Spectrometry-Based Proteomics of Epithelial ovarian cancers: A Clinical Perspective.
Qian L; Sun R; Xue Z; Guo T
Mol Cell Proteomics; 2023 Jul; 22(7):100578. PubMed ID: 37209814
[TBL] [Abstract] [Full Text] [Related]
3. hsp90aB1 as the Druggable Target of Maggot Extract Reverses Cisplatin Resistance in ovarian cancer.
Wang D; Tang X; Ruan J; Zhu Z; Wang R; Weng Y; Zhang Y; Wang T; Huang Y; Wang H; Su Z; Wu X; Tao G; Wang Y
Oxid Med Cell Longev; 2023; 2023():9335440. PubMed ID: 37180757
[TBL] [Abstract] [Full Text] [Related]
4. Single-Cell Dissection of the Multiomic Landscape of High-Grade Serous ovarian cancer.
Wang Y; Xie H; Chang X; Hu W; Li M; Li Y; Liu H; Cheng H; Wang S; Zhou L; Shen D; Dou S; Ma R; Mao Y; Zhu H; Zhang X; Zheng Y; Ye X; Wen L; Kee K; Cui H; Tang F
Cancer Res; 2022 Nov; 82(21):3903-3916. PubMed ID: 35969151
[TBL] [Abstract] [Full Text] [Related]
5. Hyperthermic intraperitoneal chemotherapy (HIPEC) with carboplatin induces distinct transcriptomic changes in ovarian tumor and normal tissues.
Moukarzel LA; Ferrando L; Dopeso H; Stylianou A; Basili T; Pareja F; Da Cruz Paula A; Zoppoli G; Abu-Rustum NR; Reis-Filho JS; Long Roche K; Tew WP; Chi DS; Sonoda Y; Zamarin D; Aghajanian C; O'Cearbhaill RE; Zivanovic O; Weigelt B
Gynecol Oncol; 2022 May; 165(2):239-247. PubMed ID: 35292180
[TBL] [Abstract] [Full Text] [Related]
6. Antibody-drug conjugate and free geldanamycin combination therapy enhances anti-cancer efficacy.
McCombs JR; Chang HP; Shah DK; Owen SC
Int J Pharm; 2021 Dec; 610():121272. PubMed ID: 34763035
[TBL] [Abstract] [Full Text] [Related]
7. Lamin-A interacting protein hsp90 is required for DNA damage repair and chemoresistance of ovarian cancer cells.
Wang Y; Chen Q; Wu D; Chen Q; Gong G; He L; Wu X
Cell Death Dis; 2021 Aug; 12(8):786. PubMed ID: 34381017
[TBL] [Abstract] [Full Text] [Related]
8. Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells.
Freund E; Miebach L; Stope MB; Bekeschus S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760187
[TBL] [Abstract] [Full Text] [Related]
9. hsp90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.
Lombardi R; Sonego M; Pucci B; Addi L; Iannelli F; Capone F; Alfano L; Roca MS; Milone MR; Moccia T; Costa A; Di Gennaro E; Bruzzese F; Baldassarre G; Budillon A
Mol Oncol; 2021 Apr; 15(4):1005-1023. PubMed ID: 33331136
[TBL] [Abstract] [Full Text] [Related]
10. Priming with HDAC Inhibitors Sensitizes ovarian cancer Cells to treatment with Cisplatin and hsp90 Inhibitors.
Rodrigues Moita AJ; Bandolik JJ; Hansen FK; Kurz T; Hamacher A; Kassack MU
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167494
[TBL] [Abstract] [Full Text] [Related]
11. Reflections and Outlook on Targeting hsp90, HSP70 and HSF1 in cancer: A Personal Perspective.
Workman P
Adv Exp Med Biol; 2020; 1243():163-179. PubMed ID: 32297218
[TBL] [Abstract] [Full Text] [Related]
12. Fn14 overcomes cisplatin resistance of high-grade serous ovarian cancer by promoting Mdm2-mediated p53-R248Q ubiquitination and degradation.
Wu AY; Gu LY; Cang W; Cheng MX; Wang WJ; Di W; Huang L; Qiu LH
J Exp Clin Cancer Res; 2019 Apr; 38(1):176. PubMed ID: 31023317
[TBL] [Abstract] [Full Text] [Related]
13. Targeted blockade of hsp90 impairs DNA-damage response proteins and increases the sensitivity of ovarian carcinoma cells to PARP inhibition.
Gabbasov R; Benrubi ID; O'Brien SW; Krais JJ; Johnson N; Litwin S; Connolly DC
Cancer Biol Ther; 2019; 20(7):1035-1045. PubMed ID: 30929564
[TBL] [Abstract] [Full Text] [Related]
14. Preparation of Folic Acid-Targeted Temperature-Sensitive Magnetoliposomes and their Antitumor Effects In Vitro and In Vivo.
Wang X; Yang R; Yuan C; An Y; Tang Q; Chen D
Target Oncol; 2018 Aug; 13(4):481-494. PubMed ID: 29992403
[TBL] [Abstract] [Full Text] [Related]
15. Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice.
Sauvage F; Fattal E; Al-Shaer W; Denis S; Brotin E; Denoyelle C; Blanc-Fournier C; Toussaint B; Messaoudi S; Alami M; Barratt G; Vergnaud-Gauduchon J
Cancer Lett; 2018 Sep; 432():103-111. PubMed ID: 29883750
[TBL] [Abstract] [Full Text] [Related]
16. Trans10,cis12 conjugated linoleic acid inhibits proliferation and migration of ovarian cancer cells by inducing ER stress, autophagy, and modulation of Src.
Shahzad MMK; Felder M; Ludwig K; Van Galder HR; Anderson ML; Kim J; Cook ME; Kapur AK; Patankar MS
PLoS One; 2018; 13(1):e0189524. PubMed ID: 29324748
[TBL] [Abstract] [Full Text] [Related]
17. Clinical, Prognostic and Therapeutic Significance of Heat Shock Proteins in cancer.
Saini J; Sharma PK
Curr Drug Targets; 2018; 19(13):1478-1490. PubMed ID: 28831912
[TBL] [Abstract] [Full Text] [Related]
18. Pathologic and treatment Outcomes Among a Geriatric Population of Endometrial cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of lap2.
Bishop EA; Java JJ; Moore KN; Walker JL
Int J Gynecol Cancer; 2017 May; 27(4):730-737. PubMed ID: 28399028
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of heat shock protein (Hsp) 90 potentiates the antiproliferative and pro-apoptotic effects of 2-(4'fluoro-phenylamino)-4H-1,3-thiazine[6,5-b]indole in A2780cis cells.
Solárová Z; Kello M; Varinská L; Budovská M; Solár P
Biomed Pharmacother; 2017 Jan; 85():463-471. PubMed ID: 27887849
[TBL] [Abstract] [Full Text] [Related]
20. Geldanamycin, an inhibitor of hsp90, increases paclitaxel-mediated toxicity in ovarian cancer cells through sustained activation of the p38/H2AX axis.
Mo Q; Zhang Y; Jin X; Gao Y; Wu Y; Hao X; Gao Q; Chen P
Tumour Biol; 2016 Nov; 37(11):14745-14755. PubMed ID: 27629142
[TBL] [Abstract] [Full Text] [Related]
[Next]
